Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > made the TOP TEN BULLBOARDS Again
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12061)
•••
Comment by ScienceFirston Mar 15, 2022 2:51pm
218 Views
Post# 34516049

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:made the TOP TEN BULLBOARDS Again

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:made the TOP TEN BULLBOARDS Again

Skys1 ... Dr. Vera is not the one that will turn TLT upside down in terms of decision to scrap or not the newsletter like you alluded to as everything was ongoing by the time she joined TLT on the FDA discussions.


The newsletter was put in place to be complementary to news releases, in a format that is more modern and visual than news releases and that can be shared through communities in a much more presentable format.   It offers more flexibility to TLT  management.  And we've seen that the "quarterly" qualifier has not restraint TLT management to focus on what matters the most;  data.


I have no doubt about Dr. Vera.  We seem to have attracted a person of talent for her role description.  

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities